search
Back to results

Improving Health Outcomes for Women Living With HIV

Primary Purpose

HIV/AIDS

Status
Completed
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
Peer Navigation
Sponsored by
University of California, San Francisco
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for HIV/AIDS focused on measuring Engagement to care, peer navigation, transgender

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)MaleDoes not accept healthy volunteers

Inclusion Criteria:

  • have either a recent HIV diagnosis (within the prior 12 months) or be out of care for previously diagnosed HIV
  • be a resident of the São Paulo area
  • consent for study staff to review their clinical records

Exclusion Criteria:

  • female sex at birth
  • less than 18 years of age
  • not HIV-positive
  • currently engaged in care
  • unable to provide informed consent
  • reside outside of the São Paulo area

Sites / Locations

  • Santa Casa Medical School

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Standard of Care

Peer Navigation

Arm Description

Participants in the standard of care arm will receive no navigation assistance to remain in care. They will provide informed consent, respond to baseline and endline surveys, and have clinic record data extracted for the 9 months of their study participation, but no additional services to remain engaged in care other than what is provided as standard by the clinic.

Participants in the peer navigation arm will meet with a peer navigator at least once per month for nine months in-person, and have at least one other navigator contact per month. Like the standard of care arm, they will provide informed consent, respond to baseline and endline surveys, and have clinic record data extracted for the 9 months of their study participation.

Outcomes

Primary Outcome Measures

Acceptability of Peer Navigation Intervention
Proportion of transgender women offered navigation services who accept invitation

Secondary Outcome Measures

Feasibility of Peer Navigation Intervention: Patient Satisfaction
Proportion in TransAmigas who report satisfaction with navigation quality, duration, contact schedule, thematic content, support.
Feasibility of Peer Navigation Intervention: Enrollment rate
Proportion of transgender women living with HIV who are screened, eligible, enrolled, and successfully complete navigation.
Feasibility of Peer Navigation Intervention: Navigator Retention
Proportion of navigators who remain in program.
Trial Planning - Linkage to ART
Time from diagnosis to antiretroviral therapy initiation
Trial Planning - Linkage to confirmatory testing
Time from diagnosis to CD4+ T-cell count results
Trial Planning - Retention
Proportion of patients who remain on treatment following 9 months of enrollment in pilot
Trial Planning - Defaulting
Proportion of participants not in care 90 days after prescribed medication estimated to last 90
Trial Planning - Adherence
Proportion of days covered (# of dispensed days of medication / # of days between refills)
Trial Planning - Viral Suppression
Proportion of participants with viral load 1) undetectable and 2) below 1000 copies/mL

Full Information

First Posted
February 28, 2018
Last Updated
November 20, 2019
Sponsor
University of California, San Francisco
Collaborators
National Institute of Mental Health (NIMH)
search

1. Study Identification

Unique Protocol Identification Number
NCT03525340
Brief Title
Improving Health Outcomes for Women Living With HIV
Official Title
Improving Health Outcomes for HIV-Positive Women in Brazil
Study Type
Interventional

2. Study Status

Record Verification Date
November 2019
Overall Recruitment Status
Completed
Study Start Date
May 7, 2018 (Actual)
Primary Completion Date
October 15, 2019 (Actual)
Study Completion Date
October 15, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of California, San Francisco
Collaborators
National Institute of Mental Health (NIMH)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study will develop and conduct a trans-specific peer navigation intervention in Brazil, which integrates the I-Care approach developed in South Africa with the Model of Gender Affirmation (GA), developed by the investigators to specifically address HIV prevention and care among trans women.
Detailed Description
Globally, transgender ('trans') women have 49 times higher odds of HIV infection compared to other groups and trans women living with HIV (TWH) access HIV care and adhere to medication at significantly lower rates than other at-risk groups. Poor engagement in HIV care for TWH is a result of reduced access to and avoidance of healthcare due to stigma and negative experiences with providers, and occurs in the context of social and economic marginalization that foments unstable employment and housing, familial alienation, limited social support, and substance abuse. Interventions to mitigate these barriers to care are critical to reducing HIV-related disparities and poor health outcomes for this highly vulnerable population, particularly where disparities are most apparent, including Brazil. Peer-based navigation (PN) interventions have demonstrated success in improving engagement in HIV care in low-resource settings. The investigators recently conducted a PN intervention ('I-Care') in rural South Africa that significantly improved both linkage to care and retention for men and women. While the PN intervention addresses HIV care engagement by providing social support and skills to work with health providers and family, it requires specific adaptation and a conceptual model that addresses the unique needs of TWH identified during formative research and in consultations with Brazilian stakeholders in 2015. The investigators propose to develop and conduct a trans-specific PN intervention in Brazil, tentatively named 'TransAmigas', which integrates the I-Care approach with the Model of Gender Affirmation (GA), developed by the research team to specifically address HIV prevention and care among trans women. The investigators will use the ADAPT-ITT methodology to develop TransAmigas, incorporating the GA model in the Brazilian context (Aim 1). The investigators will then conduct a pilot study to test the feasibility and acceptability of TransAmigas in São Paulo, Brazil (Aim 2) by randomizing TWH to the intervention (n=100) or to clinical referral (n=50). During the nine month pilot, the investigators will track both navigator and patient adherence to the program, recruitment needs, cohort retention, and reported satisfaction and preferences for program content through surveys at baseline and nine months. Finally, the investigators will prepare for a multi-site efficacy trial (Aim 3) by extracting clinical data from participants' records at the referral clinic, generating preliminary efficacy data by comparing retention in HIV care and viral load by intervention arm. Clinical data will inform future trial sample size. The study will be implemented in Sao Paulo, Brazil, where universal access to care and public support for gender transition care provide an enabling environment for this work to be most effective and where the team has established academic partnerships and a collaboration with the State-run reference and training clinical site (CRT), which includes trans-specific clinical services. If feasible, acceptable, and ultimately proven efficacious, TransAmigas will be the first evidence-based HIV care intervention for TWH globally - filling a crucial gap in programming.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
HIV/AIDS
Keywords
Engagement to care, peer navigation, transgender

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Participants will be randomly assigned 2:1 to intervention group with peer navigation or standard of care
Masking
None (Open Label)
Allocation
Randomized
Enrollment
113 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Standard of Care
Arm Type
No Intervention
Arm Description
Participants in the standard of care arm will receive no navigation assistance to remain in care. They will provide informed consent, respond to baseline and endline surveys, and have clinic record data extracted for the 9 months of their study participation, but no additional services to remain engaged in care other than what is provided as standard by the clinic.
Arm Title
Peer Navigation
Arm Type
Experimental
Arm Description
Participants in the peer navigation arm will meet with a peer navigator at least once per month for nine months in-person, and have at least one other navigator contact per month. Like the standard of care arm, they will provide informed consent, respond to baseline and endline surveys, and have clinic record data extracted for the 9 months of their study participation.
Intervention Type
Behavioral
Intervention Name(s)
Peer Navigation
Intervention Description
Peer navigators help participants identify barriers that pose challenges to the participant's engagement in care and adherence and help develop an overall action plan for addressing these barriers by identifying specific changes that can be made/attempted to overcome an identified barrier. This may involve accompanying a participant to their social services/health appointments, or assisting a participant with disclosure of her HIV status to a family member or friend. The overall goal is to develop knowledge of social/HIV-related health services and good problem-solving skills in order to tackle multiple, potentially overlapping barriers. Over time, participants are encouraged to take increasing degrees of responsibility for identifying and implementing their own problem-solving strategies.
Primary Outcome Measure Information:
Title
Acceptability of Peer Navigation Intervention
Description
Proportion of transgender women offered navigation services who accept invitation
Time Frame
Baseline
Secondary Outcome Measure Information:
Title
Feasibility of Peer Navigation Intervention: Patient Satisfaction
Description
Proportion in TransAmigas who report satisfaction with navigation quality, duration, contact schedule, thematic content, support.
Time Frame
At 9 months
Title
Feasibility of Peer Navigation Intervention: Enrollment rate
Description
Proportion of transgender women living with HIV who are screened, eligible, enrolled, and successfully complete navigation.
Time Frame
At 9 months
Title
Feasibility of Peer Navigation Intervention: Navigator Retention
Description
Proportion of navigators who remain in program.
Time Frame
At 9 months
Title
Trial Planning - Linkage to ART
Description
Time from diagnosis to antiretroviral therapy initiation
Time Frame
At 9 months
Title
Trial Planning - Linkage to confirmatory testing
Description
Time from diagnosis to CD4+ T-cell count results
Time Frame
At 9 months
Title
Trial Planning - Retention
Description
Proportion of patients who remain on treatment following 9 months of enrollment in pilot
Time Frame
At 9 months
Title
Trial Planning - Defaulting
Description
Proportion of participants not in care 90 days after prescribed medication estimated to last 90
Time Frame
At 9 months
Title
Trial Planning - Adherence
Description
Proportion of days covered (# of dispensed days of medication / # of days between refills)
Time Frame
At 9 months
Title
Trial Planning - Viral Suppression
Description
Proportion of participants with viral load 1) undetectable and 2) below 1000 copies/mL
Time Frame
At 9 months

10. Eligibility

Sex
Male
Gender Based
Yes
Gender Eligibility Description
Assigned male sex at birth, currently identify as female, transgender, transsexual, or travesti (a common term for trans women in Brazil)
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: have either a recent HIV diagnosis (within the prior 12 months) or be out of care for previously diagnosed HIV be a resident of the São Paulo area consent for study staff to review their clinical records Exclusion Criteria: female sex at birth less than 18 years of age not HIV-positive currently engaged in care unable to provide informed consent reside outside of the São Paulo area
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sheri Lippman, PhD, MPH
Organizational Affiliation
University of California, San Francisco
Official's Role
Principal Investigator
Facility Information:
Facility Name
Santa Casa Medical School
City
São Paulo
Country
Brazil

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Improving Health Outcomes for Women Living With HIV

We'll reach out to this number within 24 hrs